T

TScan Therapeutics Inc
NASDAQ:TCRX

Watchlist Manager
TScan Therapeutics Inc
NASDAQ:TCRX
Watchlist
Price: 2.97 USD 1.37%
Market Cap: 158.5m USD
Have any thoughts about
TScan Therapeutics Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
TScan Therapeutics Inc

Current Assets 274.1m
Cash & Short-Term Investments 271.1m
Other Current Assets 3m
Non-Current Assets 73.9m
Long-Term Investments 1.8m
PP&E 67.1m
Other Non-Current Assets 5m
Current Liabilities 28.7m
Accounts Payable 3.6m
Accrued Liabilities 14.8m
Other Current Liabilities 10.2m
Non-Current Liabilities 90.3m
Long-Term Debt 30.6m
Other Non-Current Liabilities 59.6m

Balance Sheet
TScan Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
42
35
161
120
133
Cash Equivalents
42
35
161
120
133
Short-Term Investments
0
0
0
0
59
Other Current Assets
1
2
4
4
2
Total Current Assets
42
36
166
124
194
PP&E Net
6
13
17
69
71
PP&E Gross
6
13
17
69
71
Accumulated Depreciation
1
2
5
10
15
Long-Term Investments
0
0
0
1
2
Other Long-Term Assets
1
1
5
5
5
Total Assets
49
N/A
50
+1%
188
+278%
199
+6%
272
+37%
Liabilities
Accounts Payable
1
3
2
3
2
Accrued Liabilities
1
4
7
10
14
Short-Term Debt
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
3
Other Current Liabilities
0
11
12
4
11
Total Current Liabilities
2
17
21
17
30
Long-Term Debt
0
0
0
29
27
Other Liabilities
4
15
6
53
65
Total Liabilities
7
N/A
33
+378%
27
-16%
100
+265%
121
+22%
Equity
Common Stock
60
60
0
0
0
Retained Earnings
17
44
92
158
248
Additional Paid In Capital
0
1
253
258
398
Total Equity
43
N/A
17
-60%
161
+835%
99
-38%
151
+52%
Total Liabilities & Equity
49
N/A
50
+1%
188
+278%
199
+6%
272
+37%
Shares Outstanding
Common Shares Outstanding
24
24
24
24
48

See Also

Discover More